Fully-synthetic adrenocorticotropic hormone (ACTH) therapy, using tetracosactide, is regaining importance. This treatment is beneficial for rheumatoid arthritis and bronchial asthma, potentially allowing for cortisone withdrawal.
Area of Science:
You might also read
Articles linked to this work by shared authors, journal, and citation graph.